• vcard
D 312.463.6352
F 312.819.1910
  • Education
    • J.D., Illinois Institute of Technology, Chicago-Kent College of Law, 1993
    • Ph.D., Medical College of Wisconsin, 1979, Microbiology
    • B.S., University of Arizona, 1974
  • Bar Jurisdictions
    • Admitted to practice before the United States Patent and Trademark Office
    • Illinois
  • Court Admissions
    • State of Illinois
    • U.S. Court of Appeals, Federal Circuit
    • U.S. District Court, Northern District of Illinois
As a lawyer, litigator, and microbiologist, David Clough, Ph.D. focuses his practice on protecting worldwide intellectual property rights on behalf of biotechnology and pharmaceutical companies. David also collaborates with clients on designing and implementing global IP strategies. Businesses frequently turn to him for IP due diligence analysis in multibillion-dollar acquisitions. David represents clients before courts and administrative agencies and in private mediation and arbitration. He also guides clients through re-examination proceedings and European oppositions.

Tapping both his legal and scientific backgrounds, David has experience prosecuting applications and rendering opinions on patents in the medical arena. These include:
  • Gene therapy
  • Genetic engineering of viruses
  • Cloning and expression of novel proteins
  • Nucleic acid diagnostics and sequencing
  • Transgenic animals
  • Immunotherapy
  • Reproductive technologies
  • Genetic engineering of antibodies
  • Screening methods for identification of drug candidates
  • Novel drug formulations and delivery systems
  • Cancer therapies, including oncolytic viruses and hormone therapies
  • Treatment of gynecologic disorders
  • Food chemistry
  • Steroid chemistry
  • Genetically engineered plants
  • Methods and compositions for treating neurological diseases
  • Medical devices

David’s background also informs his litigation, mediation, and arbitration practice. Many of his cases involved DNA fingerprinting probes, genetic engineering of antibodies, diagnostic DNA probes, and recombinant proteins.